| nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
| 1 |
A call to action for equitable care for trans and non-binary people
|
Connolly, Dean J
|
|
|
403 |
10422 |
p. 139-140
|
artikel
|
| 2 |
All children pay the price for antisemitic bias
|
Adler, Nikki R
|
|
|
403 |
10422 |
p. 143-144
|
artikel
|
| 3 |
Brazil to start widespread dengue vaccinations
|
Alves, Lise
|
|
|
403 |
10422 |
p. 133
|
artikel
|
| 4 |
Chagas disease
|
de Sousa, Andréa Silvestre
|
|
|
403 |
10422 |
p. 203-218
|
artikel
|
| 5 |
Comparative efficacy of ligelizumab versus omalizumab in chronic spontaneous urticaria
|
Moussa, Sarah
|
|
|
403 |
10422 |
p. 118-119
|
artikel
|
| 6 |
Coronary embolisation of native aortic valve debris during transcatheter aortic valve replacement: mechanical embolectomy and histopathological analysis
|
Landi, Antonio
|
|
|
403 |
10422 |
p. e5-e6
|
artikel
|
| 7 |
Daring to dream: a message of hope and togetherness
|
Nacer, Hadjer
|
|
|
403 |
10422 |
p. 136
|
artikel
|
| 8 |
Department of Error
|
|
|
|
403 |
10422 |
p. 146
|
artikel
|
| 9 |
Department of Error
|
|
|
|
403 |
10422 |
p. 146
|
artikel
|
| 10 |
Department of Error
|
|
|
|
403 |
10422 |
p. 146
|
artikel
|
| 11 |
Donald Bernard Longmore
|
Watts, Geoff
|
|
|
403 |
10422 |
p. 138
|
artikel
|
| 12 |
Efficacy and safety of ligelizumab in adults and adolescents with chronic spontaneous urticaria: results of two phase 3 randomised controlled trials
|
Maurer, Marcus
|
|
|
403 |
10422 |
p. 147-159
|
artikel
|
| 13 |
Efficacy and safety of the muscarinic receptor agonist KarXT (xanomeline–trospium) in schizophrenia (EMERGENT-2) in the USA: results from a randomised, double-blind, placebo-controlled, flexible-dose phase 3 trial
|
Kaul, Inder
|
|
|
403 |
10422 |
p. 160-170
|
artikel
|
| 14 |
End-of-life, participatory democracy, and legislative work in France
|
Delfraissy, Jean-François
|
|
|
403 |
10422 |
p. 141
|
artikel
|
| 15 |
French political bargaining over undocumented migrants’ health
|
Cailhol, Johann
|
|
|
403 |
10422 |
p. 140-141
|
artikel
|
| 16 |
Innocence and experience
|
Boyce, Niall
|
|
|
403 |
10422 |
p. 135
|
artikel
|
| 17 |
Interpreting COVID-19 data from China: a call for caution
|
Qu, Zhi
|
|
|
403 |
10422 |
p. 144
|
artikel
|
| 18 |
Interpreting COVID-19 data from China: a call for caution – Authors' reply
|
Wang, Liang
|
|
|
403 |
10422 |
p. 144-145
|
artikel
|
| 19 |
Is neutrality superior to humanity?
|
Sprung, Charles
|
|
|
403 |
10422 |
p. 142-143
|
artikel
|
| 20 |
Israel and Gaza: a quick end to a tragic but necessary war
|
Teitel, Jerome
|
|
|
403 |
10422 |
p. 143
|
artikel
|
| 21 |
Millions face food insecurity as WFP scales back in Syria
|
Samarasekera, Udani
|
|
|
403 |
10422 |
p. 132
|
artikel
|
| 22 |
Moving cholera vaccines ahead of the epidemic curve
|
Memish, Ziad A
|
|
|
403 |
10422 |
p. 127-129
|
artikel
|
| 23 |
Multiple sclerosis
|
Jakimovski, Dejan
|
|
|
403 |
10422 |
p. 183-202
|
artikel
|
| 24 |
Muscarinic drug shows efficacy in schizophrenia but much is left to be discovered
|
Cipriani, Andrea
|
|
|
403 |
10422 |
p. 120-122
|
artikel
|
| 25 |
NGOs warn over health and wellbeing in Angkor Wat
|
Tatum, Megan
|
|
|
403 |
10422 |
p. 130-131
|
artikel
|
| 26 |
Peter Hotez: physician-scientist-warrior combating anti-science
|
Samarasekera, Udani
|
|
|
403 |
10422 |
p. 134
|
artikel
|
| 27 |
Profit over people: the injustice of commercial determinants of health
|
Khajuria, Ankur
|
|
|
403 |
10422 |
p. 141-142
|
artikel
|
| 28 |
SBRT for oligoprogressive disease: using the evidence to maximise the benefits
|
Hanna, Gerard G
|
|
|
403 |
10422 |
p. 122-124
|
artikel
|
| 29 |
Sotorasib in KRASG12C mutated lung cancer
|
Olivier, Timothée
|
|
|
403 |
10422 |
p. 145
|
artikel
|
| 30 |
Sotorasib in KRASG12C mutated lung cancer – Authors' reply
|
Paz-Ares, Luis
|
|
|
403 |
10422 |
p. 145-146
|
artikel
|
| 31 |
Standard-of-care systemic therapy with or without stereotactic body radiotherapy in patients with oligoprogressive breast cancer or non-small-cell lung cancer (Consolidative Use of Radiotherapy to Block [CURB] oligoprogression): an open-label, randomised, controlled, phase 2 study
|
Tsai, Chiaojung Jillian
|
|
|
403 |
10422 |
p. 171-182
|
artikel
|
| 32 |
Tawhida Ben Cheikh: champion of women's health in Tunisia
|
Ferry, Georgina
|
|
|
403 |
10422 |
p. 137
|
artikel
|
| 33 |
The future of the global clinical trial ecosystem: a vision from the first WHO Global Clinical Trials Forum
|
Moorthy, Vasee
|
|
|
403 |
10422 |
p. 124-126
|
artikel
|
| 34 |
Time for renewed optimism for schizophrenia?
|
The Lancet,
|
|
|
403 |
10422 |
p. 117
|
artikel
|
| 35 |
Transferable exclusivity voucher: a flawed incentive to stimulate antibiotic innovation
|
Årdal, Christine
|
|
|
403 |
10422 |
p. e2-e4
|
artikel
|
Tijdschrift beschrijving